dc.contributor.author |
Weisel, Katja |
|
dc.date.accessioned |
2020-12-22T11:27:58Z |
|
dc.date.available |
2020-12-22T11:27:58Z |
|
dc.date.issued |
2020 |
|
dc.identifier.issn |
1029-2403 |
|
dc.identifier.uri |
http://hdl.handle.net/10900/110903 |
|
dc.language.iso |
en |
de_DE |
dc.publisher |
Taylor & Francis Ltd |
de_DE |
dc.relation.uri |
http://dx.doi.org/10.1080/10428194.2020.1747066 |
de_DE |
dc.subject.ddc |
610 |
de_DE |
dc.title |
Health-related quality-of-life results from the phase 3 OPTIMISMM study: pomalidomide, bortezomib, and low-dose dexamethasone versus bortezomib and low-dose dexamethasone in relapsed or refractory multiple myeloma |
de_DE |
dc.type |
Article |
de_DE |
utue.quellen.id |
20200929220116_00668 |
|
utue.publikation.seiten |
1850-1859 |
de_DE |
utue.personen.roh |
Weisel, Katja |
|
utue.personen.roh |
Dimopoulos, Meletios |
|
utue.personen.roh |
Moreau, Philippe |
|
utue.personen.roh |
Yagci, Munci |
|
utue.personen.roh |
Larocca, Alessandra |
|
utue.personen.roh |
Kanate, Abraham S. |
|
utue.personen.roh |
Vural, Filiz |
|
utue.personen.roh |
Cascavilla, Nicola |
|
utue.personen.roh |
Basu, Supratik |
|
utue.personen.roh |
Johnson, Peter |
|
utue.personen.roh |
Byeff, Peter |
|
utue.personen.roh |
Hus, Marek |
|
utue.personen.roh |
Rodriguez-Otero, Paula |
|
utue.personen.roh |
Muelduer, Ercan |
|
utue.personen.roh |
Anttila, Pekka |
|
utue.personen.roh |
Hayden, Patrick J. |
|
utue.personen.roh |
Krauth, Maria-Theresa |
|
utue.personen.roh |
Lucio, Paulo |
|
utue.personen.roh |
Ben-Yehuda, Dina |
|
utue.personen.roh |
Mendeleeva, Larisa |
|
utue.personen.roh |
Guo, Shien |
|
utue.personen.roh |
Yu, Xin |
|
utue.personen.roh |
Grote, Lara |
|
utue.personen.roh |
Biyukov, Tsvetan |
|
utue.personen.roh |
Dhanasiri, Sujith |
|
utue.personen.roh |
Richardson, Paul |
|
dcterms.isPartOf.ZSTitelID |
Leukemia & Lymphoma |
de_DE |
dcterms.isPartOf.ZS-Issue |
8 |
de_DE |
dcterms.isPartOf.ZS-Volume |
61 |
de_DE |
utue.fakultaet |
04 Medizinische Fakultät |
de_DE |